Announced Tue, 7 Jul · 14:43 IST
Routine compliance filing for Q1 FY27 demat remat certificate
Compliance View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹673.95
prior close
₹660.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.1—+0.0-4.4-5.6-3.3-4.0-5.0-5.2————
Up moveDown movePending
AI summary
Nephrocare Health Services has submitted a certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate was issued by KFIN Technologies, the company's Registrar and Share Transfer Agent, confirming that details of securities dematerialized and rematerialized during the quarter have been furnished to BSE and NSE. This is a standard quarterly compliance requirement and contains no business or financial updates.
Likely market impact
No impact on shareholders or stock price. This is a routine procedural filing required by SEBI depositories regulations.